logo of the EU drugs agency

You are viewing archived content

Please note that this page is a static copy of a previously published web page and is no longer actively maintained.
Be aware that the information contained here may be out-of-date.
For the most recent information, we recommend visiting the main website of the EMCDDA.

Table TDI-11. Age at first use distributions and primary drug distributions — EU summary of clients entering treatment, 2009 or most recent year available [see all tables in this series...]

Part (vi) New inpatient clients, primary drug distribution by age at first use (%)

Substance<1515–1920–2425–2930–3435–3940–4445+Age knownAge not known
Opiates17.644.764.370.463.856.342.631.93542299
Cocaine4.58.08.28.19.010.18.92.9553130
Stimulants13.419.411.37.47.05.76.93.6105163
Hypnotics and sedatives2.31.93.23.910.120.331.750.0334134
Hallucinogens0.10.30.30.70.30.60.00.02212
Volatile substances6.23.00.90.40.90.60.00.018815
Cannabis 54.621.710.38.07.05.15.90.71565192
Other substances 1.30.91.51.02.01.34.010.9101142
Total1113321515966903451581011387356987

Notes:

 Countries reporting data: BG, CZ, DK, DE, IE, EL, FR, CY,HU, NL, AT, PL, RO, SK, FI, SE, UK, HR, TR 

 Last data available from Poland refer to 2008.                     

 The number of treatment clients in each country is listed in Table TDI-7

 See also Table TDI-108 on distribution by country and 'General notes for interpreting data’ on the Explanatory notes and help page

Sources:

 Reitox national reports 2010 — Table TDI — inpatient treatment centres. 

(see the help page for information about formats etc.)

Page last updated: Wednesday, 29 June 2011